RISK FACTOR ANALYSIS OF ALLOGENEIC HEMAPOIETIC CELL TRANSPLANTATION (HCT) FOR FOLLICULAR LYMPHOMA (FL). A RETROSPECTIVE STUDY ON BEHALF OF THE EBMT (THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION) LYMPHOMA WORKING PARTY AND THE CIBMTR (CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH) LYMPHOMA WORKING COMMITTEE.

被引:0
|
作者
Sureda, A. [1 ]
Zang, M. [2 ]
Hari, P. [3 ]
Montoto, S. [4 ]
Laport, G. [5 ]
Lazarus, H. [6 ]
Attal, M. [7 ]
Russell, N. H. [8 ]
Thompson, K. [9 ]
Vernant, J. [10 ]
Canals, C. [11 ]
Dreger, P. [12 ]
Schouten, H. [13 ]
Pasquini, M. [14 ]
机构
[1] Addenbrookes Hosp, Cambridge, England
[2] CIBMTR, Milwaukee, WI USA
[3] Med Coll Wisconsin, Froedtert Mem Lutheran Hosp, Milwaukee, WI 53226 USA
[4] St Bartholomews Hosp, London, England
[5] Stanford Hosp Clin, Palo Alto, CA USA
[6] Univ Hosp Case Med Ctr, Cleveland, OH USA
[7] Hop Purpan, Toulouse, France
[8] City Hosp Nottingham, Nottingham, England
[9] UCHL, London, England
[10] Hop Pitie, F-75651 Paris, France
[11] Hosp Valle De Hebron, Barcelona, Spain
[12] Univ Heidelberg, Med Klin, Poliklin 5, D-6900 Heidelberg, Germany
[13] Univ Hosp Maastricht, Maastricht, Netherlands
[14] Med Coll Wisconsin, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:94 / 94
页数:1
相关论文
共 50 条
  • [31] Impact of Allogeneic Hematopoietic Cell Transplantation (allo-HCT) on the Outcomes of Angioimmunoblastic T-Cell Lymphoma (AITL): A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis
    Epperla, Narendranath
    Ahn, Kwang Woo
    Litovich, Carlos
    Kharfan-Dabaja, Mohamed A.
    Smith, Sonali M.
    Sureda, Anna
    Fenske, Timothy S.
    Hamadani, Mehdi
    BLOOD, 2018, 132
  • [32] The Impact of Advanced Patient Age on Mortality after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma: A Retrospective Study by the European Society for Blood and Marrow Transplantation Lymphoma Working Party
    Kyriakou, Charalampia
    Boumendil, Ariane
    Finel, Herve
    Schmitz, N. N. Norbert
    Andersen, Niels Smedegaard
    Blaise, Didier
    Chevallier, Patrice
    Browne, Paul
    Malladi, Ram
    Niederwieser, Dietger
    Pagliuca, Antonio
    Kroschinsky, Frank
    Montoto, Silvia
    Dreger, Peter
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (01) : 86 - 93
  • [33] Allogeneic Hematopoietic Cell Transplantation (AHCT) for Primary Cutaneous T Cell Lymphoma (CTCL): a Center for International Blood and Marrow Transplant Research (CIBMTR) Review
    Lechowicz, Mary Jo
    Agovi, Manza
    Carreras, Jeanette
    Lazarus, Hillard M.
    Laport, Ginna G.
    Montoto, Silvia
    Maloney, David G.
    Hari, Parameswaran
    BLOOD, 2010, 116 (21) : 165 - 165
  • [34] Haploidentical stem cell transplantation for patients with lymphoma: a position statement from the Lymphoma Working Party-European Society for Blood and Marrow Transplantation
    Dietrich, Sascha
    Dreger, Peter
    Hermine, Olivier
    Kyriakou, Chara
    Montoto, Silvia
    Robinson, Steve
    Schmitz, Norbert
    Schouten, Harry C.
    Sureda, Anna
    Tanase, Alina
    BONE MARROW TRANSPLANTATION, 2020, 55 (02) : 317 - 324
  • [35] Haploidentical stem cell transplantation for patients with lymphoma: a position statement from the Lymphoma Working Party-European Society for Blood and Marrow Transplantation
    Sascha Dietrich
    Peter Dreger
    Olivier Hermine
    Chara Kyriakou
    Silvia Montoto
    Steve Robinson
    Norbert Schmitz
    Harry C Schouten
    Anna Sureda
    Alina Tanase
    Bone Marrow Transplantation, 2020, 55 : 317 - 324
  • [36] Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party
    Tanase, A.
    Schmitz, N.
    Stein, H.
    Boumendil, A.
    Finel, H.
    Castagna, L.
    Blaise, D.
    Milpied, N.
    Sucak, G.
    Sureda, A.
    Thomson, K.
    Vandenberghe, E.
    Vitek, A.
    Dreger, P.
    LEUKEMIA, 2015, 29 (03) : 686 - 688
  • [37] Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party
    A Tanase
    N Schmitz
    H Stein
    A Boumendil
    H Finel
    L Castagna
    D Blaise
    N Milpied
    G Sucak
    A Sureda
    K Thomson
    E Vandenberghe
    A Vitek
    P Dreger
    Leukemia, 2015, 29 : 686 - 688
  • [38] ALLOGENEIC AND AUTOLOGOUS STEM CELL TRANSPLANTATION FOR HEPATOSPLENIC T CELL (HSTL) LYMPHOMA: A RETROSPECTIVE STUDY OF THE EBMT LYMPHOMA WORKING PARTY
    Tanase, A.
    Schmitz, N.
    Stein, H.
    Finel, H.
    Boumendil, A.
    Vitek, A.
    Avivi, I.
    Bazarbachi, A.
    Bethge, W.
    Castagna, L.
    Faber, E.
    Fegueux, N.
    Ifrah, N.
    Ljungman, P.
    Michallet, M.
    Milpied, N.
    Or, R.
    Poire, X.
    Pretnar, J.
    Rambaldi, A.
    Thomson, K.
    Vernant, J.
    Wahlin, A.
    Yeshurun, M.
    Dreger, P.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S59 - S60
  • [39] Allogeneic stem cell transplantation for adult chronic myelomonocytic leukaemia -: A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
    Kröger, N
    Zabelina, T
    Guardiola, P
    Runde, V
    Sierra, J
    van Biezen, A
    Niederwieser, D
    Zander, A
    de Witte, T
    BONE MARROW TRANSPLANTATION, 2002, 29 : S54 - S55
  • [40] Rituximab Purging and/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma: A Prospective Randomized Trial From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
    Pettengell, Ruth
    Schmitz, Norbert
    Gisselbrecht, Christian
    Smith, Graeme
    Patton, William N.
    Metzner, Bernd
    Caballero, Dolores
    Tilly, Herve
    Walewski, Jan A.
    Bence-Bruckler, Isabelle
    To, Bik
    Geisler, Christian H.
    Schots, Rik
    Kimby, Eva
    Taverna, Christian J.
    Kozak, Tomas
    Dreger, Peter
    Uddin, Ruzena
    de Elvira, Carmen Ruiz
    Goldstone, Anthony H.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (13) : 1624 - +